Page 3 - Partner Highlights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Halozyme Reports First Quarter 2021 Results
- First Quarter Revenue of $89.0 million, Up from $25.4 million in First Quarter of 2020 -
- Record Quarterly Royalties in the First Quarter of $36.9 million Representing 119% Growth over First Quarter 2020 -
- Reiterate 2021 Revenue Guidance of $375 Million to $395 Million Representing 40% to 48% Growth over 2020 Revenue -
- Reiterate 2021 GAAP Operating Income Guidance of $215 million to $235 million, Representing 49%-63% Growth over 2020 GAAP Operating Income -
News provided by
Share this article
Share this article
SAN DIEGO, May 10, 2021 /PRNewswire/  Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the first quarter ended March 31, 2021 and provided an update on its recent corporate activities and outlook. ....

San Diego , United States , Al Kildani , Helen Torley , Bristol Myers Squibb , Janssen Biotech Inc , Drug Administration , Janssen Pharmaceutical Companies Of Johnson , Halozyme Therapeutics Inc , Exchange Commission , Japan Ministry Of Health , Corporate Communications , Health Canada , Halozyme Therapeutics , Partner Highlights , Janssen Pharmaceutical Companies , Myers Squibb , Corporate Highlights , Senior Notes , Full Year , Quarterly Update Conference Call , Regarding Use , Annual Report , Investor Relations , Consolidated Statements , சான் டியாகோ ,